| Carina Champagne, DPT | |
|
21 N Main St, Attleboro, MA 02703-2217 | |
| (508) 226-2326 | |
| (508) 431-2637 |
| Full Name | Carina Champagne |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 9 Years |
| Location | 21 N Main St, Attleboro, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760927289 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2081S0010X | Physical Medicine & Rehabilitation - Sports Medicine | 187406 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sturdy Memorial Associates Inc | 9537152806 | 177 |
News Archive
Some of the federal healthcare law's requirements related to insurance exchanges threaten the autonomy of U.S. states, which need more support in establishing the marketplaces, state governors said in a letter released on Thursday. "The decision to implement health insurance exchanges requires a number of complex policy decisions amid aggressive timelines," wrote the National Governors Association in a letter to U.S. Health Secretary Kathleen Sebelius dated Nov. 2.
A novel drug proven to reduce the risk of disease progression by 79% as well as three new European Centres of Excellence, offer new hope to patients with inoperable metastatic advanced midgut neuroendocrine cancer.
Scientists at the Danish Stem Cell Center, DanStem, at the University of Copenhagen have discovered that they can make embryonic stem cells regress to a stage of development where they are able to make placenta cells as well as the other fetal cells.
BioTrends Research Group, Inc. released Wave 2 of its LaunchTrends(TM): Feraheme report, the second in a multi-phase syndicated market research project tracking the launch of AMAG's new IV iron product, Feraheme, through the first six months of product availability. Each wave of the report provides quantitative information from 50 unique Nephrologists and qualitative information from a subset of 15.
› Verified 6 days ago
| Entity Name | Sturdy Memorial Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942359856 PECOS PAC ID: 9537152806 Enrollment ID: O20070816000272 |
News Archive
Some of the federal healthcare law's requirements related to insurance exchanges threaten the autonomy of U.S. states, which need more support in establishing the marketplaces, state governors said in a letter released on Thursday. "The decision to implement health insurance exchanges requires a number of complex policy decisions amid aggressive timelines," wrote the National Governors Association in a letter to U.S. Health Secretary Kathleen Sebelius dated Nov. 2.
A novel drug proven to reduce the risk of disease progression by 79% as well as three new European Centres of Excellence, offer new hope to patients with inoperable metastatic advanced midgut neuroendocrine cancer.
Scientists at the Danish Stem Cell Center, DanStem, at the University of Copenhagen have discovered that they can make embryonic stem cells regress to a stage of development where they are able to make placenta cells as well as the other fetal cells.
BioTrends Research Group, Inc. released Wave 2 of its LaunchTrends(TM): Feraheme report, the second in a multi-phase syndicated market research project tracking the launch of AMAG's new IV iron product, Feraheme, through the first six months of product availability. Each wave of the report provides quantitative information from 50 unique Nephrologists and qualitative information from a subset of 15.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carina Champagne, DPT 281 County St, Attleboro, MA 02703-3511 Ph: (508) 226-2326 | Carina Champagne, DPT 21 N Main St, Attleboro, MA 02703-2217 Ph: (508) 226-2326 |
News Archive
Some of the federal healthcare law's requirements related to insurance exchanges threaten the autonomy of U.S. states, which need more support in establishing the marketplaces, state governors said in a letter released on Thursday. "The decision to implement health insurance exchanges requires a number of complex policy decisions amid aggressive timelines," wrote the National Governors Association in a letter to U.S. Health Secretary Kathleen Sebelius dated Nov. 2.
A novel drug proven to reduce the risk of disease progression by 79% as well as three new European Centres of Excellence, offer new hope to patients with inoperable metastatic advanced midgut neuroendocrine cancer.
Scientists at the Danish Stem Cell Center, DanStem, at the University of Copenhagen have discovered that they can make embryonic stem cells regress to a stage of development where they are able to make placenta cells as well as the other fetal cells.
BioTrends Research Group, Inc. released Wave 2 of its LaunchTrends(TM): Feraheme report, the second in a multi-phase syndicated market research project tracking the launch of AMAG's new IV iron product, Feraheme, through the first six months of product availability. Each wave of the report provides quantitative information from 50 unique Nephrologists and qualitative information from a subset of 15.
› Verified 6 days ago